Molecular Partners Ag Income Statement (2020-2025) | MOLN

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.08B-1.07B3.85B-8.61B187.09B0.01B0.00B0.20B0.00B0.00B0.00B-0.00B0.00B0.00B786.020.01B0.00B0.00B
Operating items
Research & Development 0.00B-0.03B-0.00B0.00B-0.01B-0.00B0.05B-0.00B-0.01B-0.00B0.06B-0.00B-0.01B-0.00B0.06B-0.00B-0.01B-0.00B
Selling, General & Administrative 0.00B-0.01B-0.00B0.02B0.00B-0.01B-0.00B0.02B-0.00B-0.01B-0.00B0.02B-0.00B-0.00B-0.00B-0.02B-0.00B-0.00B-0.00B
Restructuring Costs -0.00B-145.01
Other Operating Expenses -0.00B0.000.04B1.25
Operating Expenses 0.00B-0.04B-0.00B0.02B0.00B-0.02B-0.00B0.08B-0.00B-0.02B-0.00B0.08B-0.00B-0.02B-0.00B0.08B-0.00B-0.02B-0.00B
Operating Income -0.00B-0.04B-13.98B51.65B165.19B-0.01B-0.00B0.12B-16.31B-0.02B-0.00B0.00B-18.17B-0.02B-0.00B0.00B-0.00B-20.92-0.00B
EBIT -0.00B-0.04B-13.98B51.65B165.19B-0.01B-0.00B0.12B-16.31B-0.02B-0.00B0.00B-18.17B-0.02B-0.00B0.00B-0.00B-20.92-0.00B
Non-operating items
Interest & Investment Income 0.00B-0.00B717.74891.150.00B0.00B0.00B-937.370.00B0.00B0.00B-0.00B0.00B828.720.01B558.350.00B457.53
Other Non Operating Income 0.00B0.00B575.06-0.00B621.530.00B0.00B0.00B335.16-0.00B0.00B-0.00B0.00B0.00B-0.00B0.01B-700.72-0.00B261.27
Net income details
EBT -0.00B-0.04B-13.98B51.65B165.19B-0.00B-0.00B0.12B-16.31B-0.02B-0.00B-0.00B-18.17B-0.02B-0.00B0.01B-0.00B0.00B-0.00B
Profit After Tax -0.00B-0.04B-0.00B-0.07B0.00B-0.00B-0.00B0.12B-0.00B-0.02B-0.00B0.07B-0.00B-0.02B-0.00B-0.06B-0.00B-0.02B-0.00B
Income from Continuing Operations -0.00B-0.04B-13.98B51.65B165.19B-0.00B-0.00B0.12B-16.31B-0.02B-0.00B-0.00B-18.17B-0.02B-0.00B0.01B-0.00B0.00B-0.00B
Consolidated Net Income -0.00B-0.04B-13.98B51.65B165.19B-0.00B-0.00B0.12B-16.31B-0.02B-0.00B-0.00B-18.17B-0.02B-0.00B0.01B-0.00B0.00B-0.00B
Income towards Parent Company -0.00B-0.04B-13.98B51.65B165.19B-0.00B-0.00B0.12B-16.31B-0.02B-0.00B-0.00B-18.17B-0.02B-0.00B0.01B-0.00B0.00B-0.00B
Net Income towards Common Stockholders -0.00B-0.04B-13.98B51.65B165.19B-0.00B-0.00B0.12B-16.31B-0.02B-0.00B-0.00B-18.17B-0.02B-0.00B0.01B-0.00B0.00B-0.00B
Additional items
EPS (Basic) 32.18B-0.00B-0.00B0.03B-2.60B-0.00B-0.00B-0.00B
EPS (Weighted Average and Diluted) 33.02B-0.00B-0.00B0.03B-2.60B-0.00B-0.00B
Shares Outstanding (Weighted Average) 1.265.135.304.323.776.276.456.572.13
Shares Outstanding (Diluted Average) 5.004.654.223.676.276.456.57
EBITDA -0.00B-0.04B-13.98B51.65B165.19B-0.01B-0.00B0.12B-16.31B-0.02B-0.00B0.00B-18.17B-0.02B-0.00B0.00B-0.00B-20.92-0.00B
Interest Expenses 195.77-0.00B-142.68269.62-0.00B-121.150.00B602.21-0.00B-12.450.01B-11.46-0.00B-0.00B0.00B-0.00B-0.00B-196.26